HMG-CoA reductase inhibitors may affect thrombin generation by reducing factor VII activity in hyperlipidemic patients

被引：2
|
作者：
Ural, A. Ugur [1 ]
Avcu, Ferit
机构：
[1] Gulhane Mil Med Acad, Dept Hematol, Ankara, Turkey
[2] Gulhane Mil Med Acad, Canc Res Ctr, Ankara, Turkey
[3] Gulhane Mil Med Acad, Dept Med & Canc Res Ctr, Ankara, Turkey
[4] Gulhane Mil Med Acad, Sch Med, Dept Hematol, TR-06010 Ankara, Turkey
来源：
THROMBOSIS RESEARCH | 2006年 / 118卷 / 05期
关键词：
D O I：
10.1016/j.thromres.2005.11.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：665 / 666
页数：2
相关论文
共 50 条
  • [41] Synthesis and biological activity of 4,5-polymethylenepyrazole-derived HMG-CoA reductase inhibitors
    Kim, JI
    Choi, YH
    Jahng, Y
    ARCHIVES OF PHARMACAL RESEARCH, 1997, 20 (02) : 158 - 170
  • [42] Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity
    Aarons, Cary B.
    Cohen, Philip A.
    Gower, Adam
    Reed, Karen L.
    Leeman, Susan E.
    Stucchi, Arthur F.
    Becker, James M.
    ANNALS OF SURGERY, 2007, 245 (02) : 176 - 184
  • [43] Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans
    Nash, JD
    Burgess, DS
    Talbert, RL
    JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (02) : 105 - 109
  • [44] HMG-CoA reductase inhibitors potently promote endothelial progenitor cell recruitment in CAD patients
    Soullie, Thomas
    Beijk, Marcel A.
    de Winter, Robert J.
    Vos, Jeroen
    Serruys, Patrick
    Duckers, Henricus J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A282 - A282
  • [45] HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus
    Nakashima, A
    Nakashima, R
    Ito, T
    Masaki, T
    Yorioka, N
    DIABETIC MEDICINE, 2004, 21 (09) : 1020 - 1024
  • [46] EFFECTS OF BEZAFIBRATE AND OF 2 HMG-COA REDUCTASE INHIBITORS ON LIPOPROTEIN-(A) LEVEL IN HYPERCHOLESTEROLEMIC PATIENTS
    BRANCHI, A
    ROVELLINI, A
    FIORENZA, AM
    SOMMARIVA, D
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995, 33 (06) : 345 - 350
  • [47] ACUTE EFFECTS OF HMG-COA REDUCTASE INHIBITORS ON BILIARY LIPIDS IN PATIENTS WITH INTERRUPTED ENTEROHEPATIC CIRCULATION
    MURACA, M
    BAGGIO, G
    MICONI, L
    VILEI, MT
    MARTINI, S
    GABELLI, C
    BELLUCO, C
    LISE, M
    CREPALDI, G
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (02) : 204 - 208
  • [48] Relation between Baseline Lipid Levels and Effectiveness of HMG-CoA Reductase Inhibitors in Patients with Hyperlipidemia
    伍卫
    周淑娴
    韦育林
    张燕
    王景峰
    张旭明
    South China Journal of Cardiology, 2001, (01) : 13 - 16
  • [49] The use of HMG-CoA reductase inhibitors to prevent accelerated graft atherosclerosis in heart transplant patients
    Southworth, MR
    Mauro, VF
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (04) : 489 - 491
  • [50] Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia
    Glorioso, N
    Troffa, C
    Filigheddu, F
    Dettori, F
    Soro, A
    Parpaglia, PP
    Collatina, S
    Pahor, M
    HYPERTENSION, 1999, 34 (06) : 1281 - 1286
12345